Skip to main content
. Author manuscript; available in PMC: 2012 Dec 12.
Published in final edited form as: J Dev Behav Pediatr. 2012 Jul;33(6):456–468. doi: 10.1097/DBP.0b013e31825b8482

Table 3.

Estimated Effect of HIV Illness Parameters as Predictors of Emerging Symptom Cases Based on Symptom Cutoff Scores/Youth or Caregiver Report (Multivariable Logistic Regression Results)

Predictor Levels of
Predictors
Any Symptoma
ADHDb
Disruptive
Behaviorsc
Major Depression
or Dysthymiad
Separation or
General Anxietye
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Entry CD4% 25% or more vs 0–24% 0.67 (0.26, 1.76) .42 1.11 (0.44, 2.83) .83 0.64 (0.27, 1.49) .30 0.36 (0.16, 0.81) .01 0.45 (0.17, 1.16) .10
Nadir CD4% 15% or more vs 0–14% 1.05 (0.45, 2.42) .91 2.21 (0.89, 5.45) .09 1.13 (0.50, 2.53) .77 1.20 (0.53, 2.76) .66 0.95 (0.39, 2.29) .91
Entry RNA VL >10,000 vs less 1.38 (0.60, 3.16) .44 0.71 (0.31, 1.62) .42 1.39 (0.64, 3.00) .40 1.42 (0.63, 3.19) .39 1.02 (0.42, 2.44) .97
Peak RNA >100,000 vs less 1.53 (0.63, 3.74) .35 0.69 (0.31, 1.53) .36 0.55 (0.24, 1.23) .14 0.93 (0.40, 2.12) .86 0.89 (0.36, 2.20) .80
CDC class C class vs other classes 1.07 (0.39, 2.94) .90 0.63 (0.23, 1.75) .37 1.07 (0.43, 2.66) .88 1.90 (0.80, 4.51) .15 1.27 (0.47, 3.46) .63

OR, odds ratio; CI, confidence interval; CDC, Centers for Disease Control and Prevention; C, CDC Clinical Class C (severely symptomatic). Individual demographic covariates with p < .20 were considered for inclusion in a multivariable model for each disease severity factor. This resulted in a core model of covariates for all youth with PHIV.

a

Adjusted for race or ethnicity, number of life stressors.

b

Adjusted for caregiver psychiatric disorders.

c

Adjusted for gender, age at registration.

d

Adjusted for race or ethnicity.

e

Adjusted for age at registration, relationship with the caregiver.

HHS Vulnerability Disclosure